Close Menu

This story has been updated with a statement from Natera.

NEW YORK – CareDx and Stanford University have added a third patent to their patent infringement lawsuit against Natera, filing an amended complaint in the United States District Court for Delaware.

The plaintiffs now also claim that Natera has infringed on US Patent 10,329,607, which is exclusively licensed to CareDx from Stanford.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural locations.

According to NBC News, new SARS-CoV-2 variants are making it harder for researchers to model the course of the pandemic.

The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.

In Science this week: single-cell lineage tracing technique applied to study lung cancer metastasis, and more.